ProfileGDS4718 / 207921_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 54% 49% 57% 49% 50% 54% 54% 47% 48% 49% 52% 52% 52% 54% 51% 51% 49% 53% 53% 51% 50% 50% 50% 52% 54% 50% 50% 47% 55% 52% 50% 56% 51% 55% 50% 55% 50% 54% 50% 53% 51% 54% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6642553
GSM549102patient 115, normal, homogenized [OPG study]5.761654
GSM549104patient 119, normal, homogenized [OPG study]5.4518849
GSM549108patient 138, normal, homogenized [OPG study]5.9360157
GSM549119patient 077, normal, homogenized [OPG study]5.4879549
GSM549133patient 032, cancer, homogenized [OPG study]5.4344950
GSM549139patient 042, cancer, homogenized [OPG study]5.7045854
GSM549099patient 107, normal, homogenized [OPG study]5.7591354
GSM549109patient 139, normal, homogenized [OPG study]5.390447
GSM549110patient 046, normal, homogenized [OPG study]5.4076448
GSM549114patient 063, normal, homogenized [OPG study]5.4356949
GSM549122patient 082, normal, homogenized [OPG study]5.6219752
GSM549134patient 033, cancer, homogenized [OPG study]5.6076652
GSM549136patient 036, cancer, homogenized [OPG study]5.5921852
GSM549140patient 044, cancer, homogenized [OPG study]5.7010654
GSM549111patient 047, normal, homogenized [OPG study]5.5459951
GSM549113patient 057, normal, homogenized [OPG study]5.5084651
GSM549132patient 031, cancer, homogenized [OPG study]5.4309249
GSM549137patient 038, cancer, homogenized [OPG study]5.6664153
GSM549142patient 047, cancer, homogenized [OPG study]5.7912953
GSM549100patient 110, normal, homogenized [OPG study]5.6010251
GSM549107patient 135, normal, homogenized [OPG study]5.4792150
GSM549115patient 068, normal, homogenized [OPG study]5.4817450
GSM549116patient 072, normal, homogenized [OPG study]5.4868850
GSM549120patient 078, normal, homogenized [OPG study]5.6170352
GSM549131patient 030, cancer, homogenized [OPG study]5.7004454
GSM549118patient 074, normal, homogenized [OPG study]5.5147650
GSM549129patient 027, cancer, homogenized [OPG study]5.5641250
GSM549123patient 088, normal, homogenized [OPG study]5.307247
GSM549124patient 006, cancer, homogenized [OPG study]5.8329855
GSM549126patient 015, cancer, homogenized [OPG study]5.6134152
GSM549128patient 025, cancer, homogenized [OPG study]5.4963150
GSM549103patient 117, normal, homogenized [OPG study]5.8896656
GSM549117patient 073, normal, homogenized [OPG study]5.5038351
GSM549138patient 041, cancer, homogenized [OPG study]5.8187155
GSM549141patient 045, cancer, homogenized [OPG study]5.5008850
GSM549130patient 028, cancer, homogenized [OPG study]5.780855
GSM549101patient 111, normal, homogenized [OPG study]5.5253350
GSM549105patient 128, normal, homogenized [OPG study]5.7497254
GSM549106patient 134, normal, homogenized [OPG study]5.4444550
GSM549112patient 048, normal, homogenized [OPG study]5.652553
GSM549125patient 011, cancer, homogenized [OPG study]5.5714951
GSM549127patient 024, cancer, homogenized [OPG study]5.756754
GSM549135patient 035, cancer, homogenized [OPG study]5.5485851